Maverick Therapeutics is now part of Takeda. Follow us at https://www.linkedin.com/company/takeda-pharmaceuticals/ Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Maverick’s highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.
Location: United States, California, Brisbane
Member count: 10001+
Total raised: $125M
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | Takeda Ven... | takeda.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 01.01.2017 | - | $125M | - | - |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 09.03.2021 | Takeda erw... | OSAKA (Japan) und BRISBANE, Ka... | - | - | oaoa.com/n... |
| 09.03.2021 | Takeda to ... | OSAKA, Japan & BRISBANE, C... | - | - | oaoa.com/n... |
| 13.08.2017 | MPM Capita... | BRISBANE, Calif.–(BUSINESS WIR... | - | - | citybizlis... |
| - | Takeda va ... | OSAKA, Japon, et BRISBANE, Cal... | - | - | oaoa.com/n... |